Manager TitleAgeSince
Chief Executive Officer 55 2016-06-30
Investor Relations Contact - -
Sales & Marketing - 2014-10-31
Director TitleAgeSince
Director/Board Member - 2010-12-04
Director/Board Member - 2010-12-04
Director/Board Member - 2016-06-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%+0.19% - - 69.22M
+0.45%+3.13%+54.96%+125.16% 1,140B
+0.94%+4.93%+39.86%+78.72% 641B
+0.39%+1.44%+25.77%+97.48% 507B
-0.21%+1.54%+48.06%+66.52% 383B
-3.21%-2.10%+60.72%+33.22% 347B
+1.22%+1.64%+24.64%+53.51% 293B
-0.31%+1.60%+2.18%+26.63% 266B
+1.22%+4.63%+52.40%+64.85% 240B
+1.70%+3.67%+31.21%+102.15% 197B
Average +0.25%+2.92%+37.76%+72.03% 445.98B
Weighted average by Cap. +0.04%+2.98%+41.67%+84.21%
Logo Coland Holdings Limited
Coland Holdings Limited is a Taiwan-based company principally engaged in the development and distribution of pharmaceuticals. The Company provides products for the treatment of hepatitis, respiratory system diseases, urinary systems, cardiovascular and nervous system diseases. The Company also offers medical equipment, spinal instrumentations and antibiotics. Its products include Adefovir Dipivoxil Tablets, Mycophenolate Mofetil Dispersible Tablets, Tiotropium Bromide Powder For Inhalation, Amoxicillin Sodium and Clavulanate Potassium for Injection and Lamivudine Tablets. The Company operates its businesses primarily in Mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4144 Stock